Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Refractory/Relapsed RMS and STS
NCT01216839Phase 2Unknown
- Start
- Mar 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in rhabdomyosarcoma (RMS), soft tissue sarcoma (STS). Status: unknown.
02
Drugs
everolimus
03
Conditions
rhabdomyosarcoma (RMS)soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01216839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216839.